Finding Description
Based on observation, interview, and record review, the facility failed to ensure significant medications were administered as ordered.This applies to 6 residents (R10, R12, R18, R19, R20, R28) reviewed for medications.The findings include:1.On December 31, 2025, at 11:00 AM, R19 was still in bed and was restless. R19 asked for his medications and stated he did not get his morning medications. R19 stated he goes a lot of nights without getting his 9:00 PM medications until around midnight, adding he also goes a lot of days without getting his morning meds until around 11 or 12:00 PM, too. R19 stated I need them- I am very sick and me not getting my medications on time is making me sicker. R19's October 10, 2025, MDS (Minimum Data Set) showed R19 is cognitively intact.R19's Face Sheet showed he his diagnoses include malignant lung neoplasm, absence of his right and left legs above the knee, and hydradentis suppurativa (a chronic and painful skin condition that causes recurrent abscess-like lumps). R19's December 31, 2025, Order Summary Report showed Physician Orders for baclofen three times daily for muscle spasms and gabapentin three times daily for muscle spasms. R19's December 2025 MAR (Medication Administration Record) showed the two medications were scheduled to be administered daily at 9:00 AM, 5:00 PM, and 9:00 PM. The Medication Administration Audit Report for December 31, 2025, showed he received his first doses of both medications at 11:24 AM, his 5:00 PM doses at 4:35 PM (five hours later), and his 9:00 PM doses at 8:10 PM (under four hours after that). On December 31, 2025, at 11:05 AM, V20 LPN (Licensed Practical Nurse) was at his medication cart, passing medications using the facility's EMR (Electronic Medical Record). The computer screen showed the eMAR (electronic Medication Administration Record) in pink for residents whose medications had not been passed. V20 verified that the pink color for the residents showing meant that there were overdue medications and that there were 14 total residents on the hall who had overdue medications, including R19, R28, R10, R20, and R18.2. On December 31, 2025, at 11:05 AM, R28's MAR was pink. R28's Face Sheet showed his diagnoses include diabetes with hyperglycemia. R28's December 31, 2025, Order Summary Report showed Physician Orders for 6 units of short-acting insulin injected three times daily for diabetes, and 25 units of long-acting insulin injected once daily. R28's December 2025 MAR showed his short-acting insulin was scheduled for administration before meals at 7:00 AM, 11:00 AM, and 4:00 PM. The same MAR showed his daily dose of long-acting insulin was scheduled for administration at 8:00 PM. The MAR showed the 7:00 AM and 11:00 AM doses of R28's short-acting insulin were administered on December 31, 2025, and the MAR showed both doses were signed off at 11:35 AM, as does R28's Medication Administration Audit Report for December 31, 2025. R28's MAR showed his once daily long-acting insulin scheduled for 8:00 PM was signed off as administered on 12/25, 12/26, 12/27, refused on 12/28, and signed off again on 12/29. R28's December 2025 Medication Administration Audit Report showed the 8:00 PM dose on 12/25 was administered at 6:21 AM on 12/26, his 8:00 PM dose on 12/26 was administered at 5:57 AM on 12/27, his 12/27 8:00 dose was administered 12/28 at 7:08 AM, his 12/28 refused dose at 8:00 PM was administered 12/29 at 6:48 AM. The Audit Report showed his actual 12/29 8:00 PM dose was administered 14 hours later at 8:34 PM.3. On December 31, 2025, at 11:05 AM, R10's MAR was pink. R10's Face Sheet showed her diagnoses include the bi-polar type of schizoaffective disorder, and recurrent major depressive disorder. R10's December 31, 2025, Order Summary Report showed Physician Orders for benztropine mesylate two times daily for Parkinson's, and clozapine every twelve hours and lithium carbonate three times daily, both related to bipolar-type schizoaffective disorder. R10's MAR showed the benztropine and clozapine were both scheduled for administration at 9:00 AM and 9:00 PM, and lithium was scheduled for 9:00 AM, 1:00 PM, and 9:00 PM. The Medication Administration Audit Report for December 31, 2025, showed all three 9:00 AM scheduled doses were signed off as administered at 12:58 PM, with the second 1:00 PM scheduled dose of lithium signed off as administered at 12:59 PM. The same Audit Report showed on 12/30/25, R10's 9:00 AM doses of clozapine, lithium, and benztropine were signed off as administered at 2:58 PM, and her 1:00 PM scheduled dose of lithium signed off as administered at 2:20 PM. 4. On December 31, 2025, at 11:05 AM, R20's MAR was pink. R20's Face Sheet showed his diagnoses include diabetes with hyperglycemia and foot ulcer, combined heart failure, and hypertension. R20's December 31, 2025, Order Summary Report showed Physician Orders for amlodipine and lisinopril daily for hypertension with parameters to hold the medications for a systolic blood pressure value under 110, orders for 45 units of long-acting insulin injected at bedtime, and orders for short-acting insulin injected three times daily with a sliding scale.R20's MAR showed to administer the amlodipine and lisinopril at 9:00 AM. On December 31, 2025, at 12:00 PM, V26 RN (Registered Nurse) prepared R20's medications. V26 stated she just began passing medications around 11:00 AM because she had been working on the other side. V26 stated she was about to take R20's blood pressure and it was last taken the day before at 3:03 PM. The Medication Administration Audit Report for December 31, 2025, showed R20's hypertension medications were administered on December 31, 2025, at 12:09 and 12:11 PM. The Medication Administration Audit Report showed for the previous day on December 30, 2025, that R20's 9:00 AM scheduled hypertension medications were administered at 3:00 PM.R20's MAR showed to check his blood glucose and inject short-acting insulin as needed per sliding scale before meals at 6:00 AM, 11:00 AM, and 4:00 PM. R20's MAR showed the 11:00 AM insulin dose on 12/28 was administered at 6:20 PM and the 11:00 AM dose on 12/30 was administered at 2:23 PM. R20's Medication Administration Audit Report for his bedtime dose of long-acting insulin (scheduled for 9:00 PM) showed his 12/26 dose was administered at 6:05 AM on 12/27, his 12/27 dose was administered on 12/28 at 7:11 AM, his 12/28 dose was administered on 12/29 at 6:43 AM, and his 12/29 dose was administered at 8:47 PM, approximately 14 hours later.5. On December 31, 2025, at 11:05 AM, R18's MAR was pink. R18's Face Sheet showed her diagnoses include malignant neoplasm of brain and epileptic seizures. R18's December 31, 2025, Order Summary Report showed Physician Orders for levetiracetam and lacosamide twice daily for seizures. R18's MAR showed both seizure medications were to be administered twelve hours apart at 9:00 AM and 9:00 PM. R18's December Medication Administration Audit Report showed the two 9:00 AM seizure medications were administered on 12/26 at 10:41 and 10:44 AM and the 9:00 PM dose was administered on the next day on 12/27 at 6:03 and 6:04 AM; her 12/27 9:00 AM doses were administered seven hours later at 1:06 PM and her 12/27 9:00 PM doses were administered on 12/28 at 6:52 AM; her 12/28 9:00 AM doses were administered at 6:24 PM and her 9:00 PM doses were administered on 12/29 at 6:30 AM; her 12/29 9:00 AM doses were administered just over seven hours later at 1:45 PM, her 12/29 9:00 PM seizure medications were administered at 8:52 PM, just over seven hours after that, making that a third dose within 15 hours. The Audit Report showed her 12/30 9:00 AM doses were administered at 2:58 PM, with the 12/30 9:00 PM doses not being signed off as administered at all. The same Audit Report showed the 12/31 9:00 AM doses were administered at 1:00 PM, 22 hours later.6. R12's Face Sheet showed his diagnoses include functional quadriplegia, dysphagia, and history of acute respiratory failure and pneumonia. R12's December 24, 2025, hospital Discharge Summary showed Weaned off oxygen successfully. [Intravenous] Zosyn (antibiotic) transitioned to [oral] antibiotic. R12's Transition of care section showed 1. Medication changes: start levofloxacin (antibiotic) 750 mg (milligrams) daily for five days.R12's Order Summary Report had the order transcribed to give levofloxacin 750 mg two times a day via his gastrostomy tube every five days. R12's MAR showed 9:00 AM and 5:00 PM doses were signed off as administered on 12/25 and 12/30, instead of once daily for five straight days. Further, R12's Medication Administration Audit Report showed his 9:00 AM dose on 12/30 was administered at 5:19 PM, and his 5:00 PM dose was administered at 7:13 PM, less than two hours later. R12's Advanced Practice Nurse progress note late entry from date of service of 12/29 also showed [History of Present Illness]: .started on a five-day course of levofloxacin 750 mg one tab via [gastrostomy tube] two times a day for infection prophylaxis following [Emergency Department] visit.started 12/25 with no end date.R12's December 25, 2025, pharmacy Physician's Order Note from 7:38 AM showed This order is outside the recommended dose or frequency. levofloxacin Oral Tablet 750 MG (Levofloxacin) Give 1 tablet via G-tube two times a day every 5 days for prophylaxis- The frequency of 2 times per 5 days is below the usual frequency of every 2 days to daily.The facility's undated Policy and Procedure- Medication Administration Errors showed Procedure: A medication error is any preventable event that may cause or lead to inappropriate medication use. Such events may be related to professional practice. administration. The Medication Administration Error Policy listed Medication not administered within the allowed time frame which is greater than one hour from its scheduled administration time or exceeds the time in relation to meals, and missed medication as administration-based errors.